期刊文献+

人白细胞介素-29基因的克隆及真核表达 被引量:6

Cloning and eukaryotic expression of human interleukin-29 gene
原文传递
导出
摘要 目的克隆人白细胞介素-29(Interleukin-29,IL-29)基因并进行真核表达。方法提取人外周血单个核细胞(PBMC)总RNA,经逆转录合成cDNA,以其为模板,PCR扩增IL-29基因,插入真核表达载体pPIC9K,构建重组真核表达质粒pPIC9K-29,转化毕赤酵母GS115,甲醇诱导表达,经SDS-PAGE和Western blot鉴定表达产物。结果扩增的IL-29基因序列与GenBank中登录的序列(NM_172140)相同;重组表达质粒pPIC9K-29经双酶切及测序证实构建正确;表达产物经SDS-PAGE分析,可见相对分子质量分别约30 000和27 000的特异蛋白条带,经Western blot分析,均可与羊抗人IL-29多抗发生特异性反应。结论已克隆并在毕赤酵母GS115中表达了人IL-29,为进一步研究其生物学活性及其应用奠定了基础。 Objective To clone human interleukin-29 (IL-29) gene and express in eukaryotic cells. Methods Total RNA was extracted from human peripheral blood mononuclear cells (PBMCs) and reversely transcribed into cDNA as a template with which IL-29 gene was amplified by PCR and inserted into eukaryotic expression vector pPIC9K. The constructed recombinant plasmid pPIC9K-29 was transformed to Pichia pastoris GSll5 and induced with methanol, and the expressed product was identified by SDS- PAGE and Western blot. Results The sequence of amplified IL-29 gene was identical to that reported in GenBank (NM_172140). Restriction analysis and sequencing proved that recombinant plasmid pPIC9K-29 was constructed correctly. Specific protein bands with relative molecular masses of about 30 000 and about 27 000 respectively were observed on SDS-PAGE profile of expressed product, both of which showed specific reactions with goat anti-human IL-29 polyclonal antibody. Conclusion Human IL-29 gene was cloned and expressed in P. pastoris GS115, which laid a foundation of further study on biological activity and application of IL- 29.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第4期446-448,共3页 Chinese Journal of Biologicals
关键词 白细胞介素-29 基因克隆 真核细胞 基因表达 Interleukin-29 Gene cloning Eukaryotic cells Gene expression
  • 相关文献

参考文献11

  • 1Sheppard P,Kindsvogel W,Xu W. IL-28,IL-29 and their class Ⅱ cytokine receptor IL-28R[J].Nature Immunology,2003,(01):63-68.doi:10.1038/ni873.
  • 2Kotenko SV,Gallagber G,Baurin VV. IFN-λs mediate antivira]protection through a distinct class Ⅱ cytokine receptor complex[J].Nature Immunology,2003,(01):69-77.doi:10.1038/ni875.
  • 3Miknis Z J,Magracheva E,Li W. Crystal structure of human inerferon-λ1 in complex with its high-affinity receptor interferonλR1[J].Journal of Molecular Biology,2010,(04):650-664.
  • 4Muir AJ S,Shiffman ML,Zaman A. A phase 1b doseranging study of 4 weeks of PEG-interferon(IFN) lambda(PEG-rIL-29) in combination with Ribavirin(RBV) in patients with chronic genotype 1 hepatitis C virus(HCV) infection[A].2009.
  • 5Zhou Z,Hamming OJ,Ank N. Type Ⅲ interferon(WN)induces a type Ⅰ IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases[J].Journal of Virology,2007,(14):7749-7758.doi:10.1128/JVI.02438-06.
  • 6Wang J,Oberley-Deegan R,Wang S. Differentiated human alveolar type Ⅱ cells secrete antiviral IL-29(IFN-lambda 1)in response to inlluenza A infection[J].Journal of Immunology,2009,(03):1296-1304.
  • 7Li Q,Kawamura K,Ma G. Interferon-lambda induces G1 phase arrest or apoptosis in oesoghageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents[J].European Journal of Cancer,2010,(01):180-190.
  • 8Sato A,Ohtsuki M,Hata M. Antitumor activity of IFN-lamhda in murine tumor models[J].Journal of Immunology,2006,(12):7686-7694.
  • 9Dai J,Megjugorac NJ,Gallagher GE. IFN-lambdal(IL-29)inhibits GATA3 expression and suppreses Th2 responses in human naive and memory T cells[J].Blood,2009,(23):5829-5838.
  • 10Dumoutier L,Lejeune D,Hor S. Cloning of a new type Ⅱ eytokine receptor activating signal transducer and aetivator of transcniption(STAT)1,STAT2 and STAT3[J].Biochemical Journal,2003,(Pt 2):391-396.

同被引文献62

  • 1Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R [J]. Nature Immunol, 2003, 4 ( 1 ): 63-68.
  • 2Kotenko SV, Gallagber G, Baurin W, et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex [J]. Nature Immunol, 2003, 4 (1): 69-77.
  • 3Zhou Z, Hamming OJ, Ank N, et ol. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases [J]. J Virol, 2007, 81 ( 14): 7749-7758.
  • 4Horton P, Park KJ, Ohayashi T, et al. Protein subcellular local- ization prediction with WoLF PSORT [ C ]. Proc Asian Pacific Bioinformatics Conference APBC06, Taipei, 2006: 39-48.
  • 5Arnold K, Bordoli L, Kopp J, et al. The SWISS-MODEL workspace: a web-based environment for protein structure homology modeling [J]. Bioinformatics, 2006, 22(2): 195-201.
  • 6Schwede T, Kopp J, Guex N, et al. SWISS-MODEL: an auto- mated protein homology-modeling server [J]. Nucleic Acids Res, 2003, 31(13): 3381-3385.
  • 7Gad HH, Dellgren C, Hamming OJ, et al. Interferon-λ is func- tionally an interferon but structurally related to the interleukin- 10 family [J]. J Biol Chem, 2009, 284(31): 20869-20875.
  • 8Dumoutier L, Lejeune D, Hor S, et al. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)I, STAT2 and STAT3 [J]. Biochem J, 2003, 370 (Pt 2): 391-396.
  • 9Dellgren C, Gad HH, Hamming OJ, et al. Human interferon-λ3 is a potent member of the type III interferon family [J]. Genes Im- mun, 2009, 10(2): 125-131.
  • 10Miknis ZJ, Magracheva E, Li W, et al, Crystal structure of hu- man inerferon-λ1 in complex with its high-affinity receptor inter- feron-λR1 [J]. J Mol Biol, 2010, 404 (4): 650-664.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部